21st IMS Annual Meeting
Mark your calendars for the 21st IMS Annual Meeting in Rio de Janeiro, Brazil!
The International Myeloma Society Meeting is the defining annual meeting in myeloma with a focus on both the basic, preclinical and the clinical aspects.
This year’s program includes:
- Six thematic sessions on:
- Â Precursor Disease
- Â Newly Diagnosed Multiple Myeloma
- Â High Risk Disease
- Â Relapsed: Treatments Outside of Immunotherapy
- Â Immunotherapy
- Novel Biomarkers – personalizing therapy in myeloma
- Talks and symposia on pressing topics led by the KOL of the myeloma community
- Special Sessions for trainees and local attendees
- Keynote addresses
- Â Joint sessions with regulatory agencies and other organisations
- Special sessions on MRD and New Endpoints
- Oral Abstracts (on Basic Biology, Preclinical Trials, and Clinical Studies)
- Â Poster Presentations
Our sponsors:
Titanium
Platinum
Gold
Bronze
Educational Workshop Johannesburg, South Africa
Join us for a dynamic educational workshop on the diagnosis, treatment, and monitoring of plasma cell malignancies, including current practices and opportunities for improvement. This workshop will include lectures plus roundtable discussions around hot and controversial topics, featuring point-counterpoint conversations between invited speakers and local hematologists based on both challenging questions and clinical cases.
6th Immune Effector Cell Therapies in Multiple Myeloma Workshop
IMS is pleased to announce that the 6th Annual Immune Effector Cell Therapies in Multiple Myeloma Workshop will take place from March 28-29, 2025 in Boston, MA.
More details will be available soon!Â
Educational Workshop Marrakech, Morocco
Join us for a dynamic educational workshop on the diagnosis, treatment, and monitoring of plasma cell malignancies, including current practices and opportunities for improvement. This workshop will include lectures plus roundtable discussions around hot and controversial topics, featuring point-counterpoint conversations between invited speakers and local hematologists based on both challenging questions and clinical cases.
Why Become a Member
The International Myeloma Society is a professional, scientific, and medical society established to bring together clinical and experimental scientists involved in the study of myeloma. The purpose of this society is to promote research, education, clinical studies (including diagnosis and treatment), workshops, conferences, and symposia on all aspects of multiple myeloma worldwide.
The IMS is a membership organization comprised of basic research scientists, and clinical investigators in the field along with physicians and other healthcare practitioners.
